OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 3.186
-0.020 (-0.62%)
Aug 3, 2026, 2:51 PM CET
OSE Immunotherapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, OSE Immunotherapeutics stock has a consensus rating of "Strong Buy" and an average price target of €12.70. The average 1-year stock price forecast is 298.62% higher than the current stock price, while the lowest is €8.20 (+157.38%) and the highest is €21.00 (+559.13%).
Price Target: €12.70 (+298.62%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Apr 30, 2026.
Analyst Ratings
The average analyst rating for OSE Immunotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Kepler Capital | Kepler Capital | Buy Maintains €8.20 | Buy | Maintains | €8.20 | +157.38% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
4.90M
from 2.69M
Increased by 82.09%
Revenue Next Year
10.53M
from 4.90M
Increased by 114.90%
EPS This Year
-1.30
from -1.69
EPS Next Year
-1.14
from -1.30
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.